Kiniksa Pharmaceuticals International Earnings
NASDAQ: KNSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 27, 2026
Fiscal period
Sep/2026
EPS estimate
$0.39
Kiniksa Pharmaceuticals International earnings summary
Kiniksa Pharmaceuticals International is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $0.39. In its most recent report on Apr 28, 2026 (Q1 2026), KNSA posted EPS of $0.27. Revenue for the quarter was $214.3 million.
Quarterly EPS is up 145.5% from the same quarter a year earlier. Across the last 16 reports, KNSA shares moved an average of 5.4% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
KNSA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Apr 28, 2026 | — | $0.27 | — | +6.0% |
| Feb 24, 2026 | — | $0.18 | — | +3.8% |
| Oct 28, 2025 | — | $0.23 | — | +3.7% |
| Jul 29, 2025 | — | $0.23 | — | +0.5% |
| Apr 29, 2025 | — | $0.11 | — | -5.9% |
| Feb 25, 2025 | — | $-0.11 | — | +6.1% |
| Oct 29, 2024 | — | $-0.18 | — | +1.7% |
| Jul 25, 2024 | — | $-0.06 | — | -3.9% |
| Apr 25, 2024 | — | $-0.25 | — | +12.3% |
| Feb 28, 2024 | — | $0.37 | — | -4.3% |
| Nov 2, 2023 | — | $-0.20 | — | -10.9% |
| Aug 1, 2023 | — | $0.21 | — | -6.6% |
| May 4, 2023 | — | $-0.18 | — | -0.3% |
| Mar 2, 2023 | — | $0.07 | — | -2.4% |
| Nov 3, 2022 | — | $3.18 | — | +10.8% |
| Aug 4, 2022 | — | $-0.29 | — | -7.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.